In addition, Beta Bionics sold 1,000,000 shares of its common stock in a concurrent private placement to one of its existing investors at the initial public offering price of $17.00 per share. The ...

Beta Bionics closed an upsized IPO, raising approximately $212.1 million, trading on Nasdaq under the ticker BBNX. Beta Bionics, Inc. has successfully completed an upsized initial public offering ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Beta Bionics began trading on Thursday after filing to go public in early January. The diabetes technology ...

Beta Bionics began trading on Thursday after filing to go public in early January. The diabetes technology firm raised $204 million in an upsized initial public offering. Beta Bionics priced 12 ...

IRVINE, Calif. – Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share. The gross proceeds to ...

Beta Bionics announces upsized IPO of 12 million shares at $17 each, aiming for $204 million in gross proceeds. Beta Bionics, Inc., a leader in diabetes management solutions, has announced the ...

Beta Bionics Inc., an Irvine-based medical device company, today began publicly trading on the Nasdaq Capital Market under the ticker BBNX. The company raised an upsized offering of $204 million by ...

Beta Bionics celebrates its formal listing on the Nasdaq market. [Image from the company’s LinkedIn page] Beta Bionics (Nasdaq:BBNX) has gone public after pricing a significantly upsized initial ...

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized ...

Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering. In a recent SEC filing, the company said it was now looking to offer 10M ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering. In its latest SEC filing, the company said it was planning to offer 7.5M ...

Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its artificial pancreas system for people with Type 1 diabetes. The California ...